Application of triterpenoid in preventing or treating hyperlipidemia
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- CHINA PHARM UNIV
- Publication Date
- 2015-11-25
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of natural medicines, and relates to the use of betulinic acid to prevent or treat hyperlipidemia. Background technique
[0002] Hyperlipidemia refers to excessive blood lipid levels, a metabolic disease in which one or more lipids in plasma are higher than normal due to abnormal fat metabolism or operation. Mainly include elevated triglycerides and cholesterol Elevated biliary triglycerides. The increase of blood lipid level will make the incidence of cardiovascular disease and mortality increase with the increase of serum total cholesterol and LDL cholesterol level. In addition, elevated triglycerides and cholesterol are also closely related to atherosclerosis, non-alcoholic fat, and type II diabetes. Therefore, it is of great clinical significance to develop good drugs for the treatment of hyperlipidemia. The liver is the main organ of lipid metabolism, so normal liver cells LO2 and liver cancer cells HepG2 are ...